- * Male and female subjects ≥ 25 years of age with a diagnosis of type 2 diabetes mellitus (T2DM)
- * Urinary ACR ≥ 150 mg/g
- * eGFR \> 20 mL/min/1.73m2
- * Glycosylated HbA1c \< 12%
Diabetic Kidney Disease (DKD)
Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease
NCT04419467 | PHASE 2 | INTERVENTIONAL
This phase 2a, double-blind, randomized, placebo-controlled study will assess the efficacy, safety, tolerability, and pharmacokinetics (PK), of repeat doses of CSL346 in subjects with diabetic kidney disease (DKD) and albuminuria receiving standard of care treatment.
Trial Information
If interested, contact clinicaltrials@cslbehring.com for more information
CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy
California Kidney Specialists (CKS) Citrus Office
Covina,California,United States,91702
Valley Research Fresno
Fresno,California,United States,93720
Torrance Clinical Research (TCR) Lomita
Lomita,California,United States,90717
Renal Medical AssociateNARI
Lynwood,California,United States,90260
Amicis Research Center
Northridge,California,United States,91324
California Medical Research Associates, Inc
Northridge,California,United States,91324
Riverside Nephrology Group
Riverside,California,United States,92503
West Orange Endocrinology
Ocoee,Florida,United States,34761
EastWest Medical Research Institute
Honolulu,Hawaii,United States,96814
Omega Clinical Research
Metairie,Louisiana,United States,70006
Tufts Medical Center
Boston,Massachusetts,United States,02111
Renal and Transplant Associates
Springfield,Massachusetts,United States,01107
University of Missouri Health System
Columbia,Missouri,United States,65212
Palm Medical Group, LLC Las Vegas
Las Vegas,Nevada,United States,89148
Center for Thyroid & Parathyroid Disorders
Staten Island,New York,United States,10301
Physicians East, P.A. Endocrinology
Greenville,North Carolina,United States,27834
Vanderbilt University School of Medicine
Nashville,Tennessee,United States,37232
Juno Research, L.L.C.
Houston,Texas,United States,77040
The Endocrine Center
Houston,Texas,United States,77079
Renal Associates, P.A. San Antonio
San Antonio,Texas,United States,78215
Primary Care Providers of Texas
San Antonio,Texas,United States,78224
Diabetes and Metabolism Specialists (DMS) San Antonio
San Antonio,Texas,United States,78231
Hunter Diabetes Centre The AIM Centre
Merewether,New South Wales,Australia,2291
St Vincent's Hospital
Fitzroy,Victoria,Australia,3065
The Austin Hospital
Heidelberg,Victoria,Australia,3084
The Royal Melbourne Hospital
Parkville,Victoria,Australia,3052
Sunshine Hospital
St Albans,Victoria,Australia,3021
Lyell McEwin Hospital
Elizabeth Vale,Australia,5112
University Health Network
Toronto,Ontario,Canada,M5G2N2
Kaplan Medical Center
Reẖovot,Israel,76100
Tel Aviv Sourasky Medical Center
Tel Aviv-Yafo,Israel,64239
Middlemore Hospital
Auckland,New Zealand,2025
Christchurch Hospital
Christchurch,New Zealand,8011
Lipid and Diabetes Research Group
Christchurch,New Zealand,8011
Endocrine Associates Wellington
Wellington,New Zealand,6140
Fundacin de Investigacin
San Juan,Puerto Rico,00927
University of Puerto Rico Puerto Rico Clinical and TRC
San Juan,Puerto Rico,00935
Study Eligibility Criteria
Additional Studies
Additional studies can be found at ClinicalTrials.gov